HealthEquity Reports Fourth Quarter and Fiscal Year Ended January 31, 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- US stock futures steady as oil jumps to two-week high ahead of key earnings
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's Russian supply announcements
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- Iren shares jump 5% in premarket trade on report of Anthropic AI cloud deal
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Stryker invests $400M in CMR Surgical with option to acquire
- Enovix posts $11M in Q3 revenue, beats guidance by 10%
- Deutsche Bank Upgrades AST Spacemobile (ASTS) to Buy
HealthEquity, Inc (HQY) PT Raised to $98 at Oppenheimer
March 19, 2019 9:30 AM EDTOppenheimer analyst Mohan Naidu raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $98.00 (from $74.00) while maintaining a Outperform rating.
The analyst commented, "HQY wrapped up the year at the higher end of the pre-released FY19 numbers at revenue/adj. EPS of... More
HealthEquity (HQY) Tops Q4 EPS by 5c, FY EPS Guidance Misses
March 18, 2019 4:08 PM EDTHealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.27, $0.05 better than the analyst estimate of $0.22. Revenue for the quarter came in at $75.8 million versus the consensus estimate of $74.09 million.
GUIDANCE:
HealthEquity sees FY2020 EPS of $1.23-$1.29, versus the consensus of $1.31. HealthEquity sees... More



